News Releases

Filter News Releases by year:
2023 | 2022 | 2021 | 2020 | 2019

1 Results

May 2023

First-in-Human Trial of Oral Drug to Remove Radioactive Contamination Begins

May 15, 2023

A first-in-human clinical trial of an experimental oral drug for removing radioactive contaminants from inside the body has begun. The trial is testing the safety, tolerability and processing in the body of escalating doses of the investigational drug product HOPO 14-1 in healthy adults. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is funding the Phase 1 trial, which is sponsored and conducted by SRI International of Menlo Park, California.